NCT03126916 2026-02-27Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)Children's Oncology GroupPhase 3 Recruiting750 enrolled
NCT02176967 2025-12-22Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk NeuroblastomaChildren's Oncology GroupPhase 3 Active not recruiting621 enrolled